Products for Research Use Only
RegisterLogin

Levilimab

CAT: 0804-HY-P99702-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99702-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Levilimab (BCD-089) is a fully humanized anti-interleukin-6 receptor (IL-6R) monoclonal antibody. Levilimab is an inflammation-alleviating antibody. Levilimab can be used for the research of rheumatoid[1].
CAS Number
2035008-70-7
Product Name Alternative
BCD-089
UNSPSC
12352203
Target
Interleukin Related
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/levilimab.html
Purity
98.82
Solubility
10 mM in DMSO
Smiles
[Levilimab]
Molecular Weight
(145.7 kDa)
References & Citations
[1]Pum A, et al. Cytokines and Chemokines in SARS-CoV-2 Infections-Therapeutic Strategies Targeting Cytokine Storm. Biomolecules. 2021 Jan 12;11 (1) :91.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3

Alternative Products

CatalogName
T77062-01Levilimab
591964Levilimab (IL6R)
GTR18337701-01Levilimab Antibody
MBS1563467-01Research Grade Levilimab
KBI1426KRIBIOLISA™ Levilimab ELISA
E55B0382Levilimab (Reference antibody)
ICH5639-25mgLevilimab Biosimilar - Research Grade
A138442Levilimab Biosimilar (Monoclonal, IgG1)
GTR18780647-01(Levilimab) Biosimilar Reference Antibody
GTR18697842-01Levilimab Human Monoclonal Antibody

Popular Products